FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Aurobindo Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524804 NSE Symbol: AUROPHARMA P/E (TTM) :34.65
ISIN Demat:INE406A01037 Div & Yield %:0.64 EPS (TTM) :33.56
Book Value (RS) :318.5455537 Market Cap (Rs Cr.):68144.66 Face Value (RS) :1
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.170.180.270.340.39
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio1.721.891.701.601.51
Fixed Assets2.141.822.462.302.52
Inventory3.422.753.443.213.32
Debtors3.002.282.702.432.53
Interest Cover Ratio15.0497.66147.2010.749.51
PBIDTM (%)16.9218.3429.7623.0921.28
PBITM (%)13.5214.6626.6819.5517.91
PBDTM (%)16.0218.1929.5821.2719.40
CPM (%)13.0216.5722.7617.5815.85
APATM (%)9.6212.8919.6714.0412.48
ROCE (%)8.398.4922.9415.9714.82
RONW (%)7.028.8121.4915.3814.34

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)